Skip to product information
Retatrutide
★★★★
★
4.7
·
200+ orders served
Retatrutide is a next-generation synthetic peptide designed for advanced preclinical research. As a triple incretin receptor agonist, it simultaneously targets GLP-1R, GIPR, and glucagon receptors, making it one of the most mechanistically complex compounds available for metabolic signalling research in 2026.
Available in 10mg, 20mg, 30mg, 40mg, 50mg and 60mg vials. Every batch is HPLC tested and independently verified to a minimum of 99% purity. Certificate of Analysis available on request.
Research applications include:
- Multi-receptor agonism studies (GLP-1R / GIPR / Glucagon receptor)
- Metabolic and energy homeostasis pathway modelling
- Comparative receptor engagement vs single and dual agonist compounds
- Gut-brain axis and appetite regulation research
Product specifications:
- Form: Lyophilised powder
- Purity: ≥99% (HPLC verified)
- Storage: −20°C, protected from light and moisture
- Available sizes: 10mg · 20mg · 30mg · 40mg - 50mg - 60mg
- Origin: UK warehouse, same day dispatch
✓
Multibuy Discount Available
Buy 2 save 5%
Buy 3 save 10%
Buy 4 save 15%
Buy 5+ save 20%
£50.00
Sale price
£50.00
Regular price
£60.00
✓ 99%+ Purity Guaranteed
✓ COA Available
✓ Same Day UK Dispatch
✓ Secure Checkout
⚠ For research purposes only. This product is not intended for human or veterinary use, consumption, or self-administration. Must be handled by qualified professionals in a suitable laboratory environment. Not evaluated by the MHRA or any regulatory authority for therapeutic use. Read full disclaimer →